Table 2.
Medication | Donor Age (yr; %; n = 74)
|
P | ||
---|---|---|---|---|
<41(n = 24) | 41 to 53(n = 27) | >53(n = 23) | ||
Immunosuppressive agents | ||||
cyclosporin A | 25.0 | 14.8 | 26.1 | 0.197 |
tacrolimus | 75.0 | 85.2 | 73.9 | 0.557 |
MMF | 100.0 | 100.0 | 100.0 | NS |
steroids | 100.0 | 100.0 | 100.0 | NS |
BP- and lipid-lowering agents | ||||
ACEI/ARB | ||||
3 mo | 26.1 | 17.9 | 17.4 | 0.705 |
12 mo | 54.2 | 51.9 | 69.6 | 0.401 |
CCB | ||||
3 mo | 45.8 | 51.9 | 65.2 | 0.428 |
12 mo | 50.0 | 51.9 | 65.2 | 0.517 |
BB | ||||
3 mo | 45.8 | 55.6 | 60.9 | 0.673 |
12 mo | 54.2 | 33.3 | 56.5 | 0.187 |
diuretics | ||||
3 mo | 4.2 | 3.7 | 4.3 | 0.991 |
12 mo | 16.7 | 18.5 | 13.0 | 0.870 |
statins | ||||
3 mo | 37.5 | 25.9 | 26.1 | 0.492 |
12 mo | 41.7 | 29.6 | 52.2 | 0.367 |
ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; BB, β blockers; CCB, calcium channel blockers; MMF, mycophenolate mofetil.